Evidence map›Paper›PMID 36042049›Full record

ArticleArchives of microbiology2022

An extended catalogue of ncRNAs in Streptomyces coelicolor reporting abundant tmRNA, RNase-P RNA and RNA fragments derived from pre-ribosomal RNA leader sequences.

Walter Arancio, Swonild I Genovese, Viviana Benfante, Giuseppe Gallo, Claudia Coronnello

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Walter ArancioRi.MED Foundation, via Bandiera, 11, 90133, Palermo, Italy. warancio@fondazionerimed.com.ORCID http://orcid.org/0000-0002-6736-7734
Swonild I Genovese, Palermo, Italy.ORCID http://orcid.org/0000-0001-6302-5879
Viviana BenfanteRi.MED Foundation, via Bandiera, 11, 90133, Palermo, Italy.ORCID http://orcid.org/0000-0002-3629-355X
Giuseppe Gallo *Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90100, Palermo, Italy.ORCID http://orcid.org/0000-0003-4727-5653
Claudia Coronnello *Ri.MED Foundation, via Bandiera, 11, 90133, Palermo, Italy.ORCID http://orcid.org/0000-0001-5962-8642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces coelicolor is a model organism for studying streptomycetes. This genus possesses relevant medical and economical roles, because it produces many biologically active metabolites of pharmaceutical interest, including the majority of commercialized antibiotics. In this bioinformatic study, the transcriptome of S. coelicolor has been analyzed to identify novel RNA species and quantify the expression of both annotated and novel transcripts in solid and liquid growth medium cultures at different times. The major characteristics disclosed in this study are: (i) the diffuse antisense transcription; (ii) the great abundance of transfer-messenger RNAs (tmRNA); (iii) the abundance of rnpB transcripts, paramount for the RNase-P complex; and (iv) the presence of abundant fragments derived from pre-ribosomal RNA leader sequences of unknown biological function. Overall, this study extends the catalogue of ncRNAs in S. coelicolor and suggests an important role of non-coding transcription in the regulation of biologically active molecule production.

Indexed as

Streptomyces coelicolorRibonuclease PRNA, BacterialRNA, RibosomalRibonuclease PRNA, BacterialRNA, RibosomaltmRNALeader sequencencRNARNase PRNAseqStreptomyces coelicolortmRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.